Article

OptiMedica moves to new headquarters

OptiMedica Corp. has tripled its operation size by moving to a new 55,000-square-foot facility in Sunnyvale, CA.

Sunnyvale, CA-OptiMedica Corp. has tripled its operation size by moving to a new 55,000-square-foot facility in Sunnyvale, CA.

The expanded global headquarters building, which houses all business functions, will serve as the base of the company’s worldwide commercial launch of a proprietary laser platform (Catalys Precision Laser System) for cataract surgery, according to the company.

“The move to our expanded headquarters marks the beginning of an exciting new growth phase for OptiMedica,” said Mark J. Forchette, the company’s president and chief executive officer. “Worldwide surgeon interest in [the laser platform] is significant and increasing every day, and our new, larger facility will enable us to scale our operations rapidly, serve customer needs appropriately, and meet the growing global demand.”

The laser platform has FDA 510(k) market clearance and CE mark approval for capsulotomy and lens fragmentation performed during cataract surgery.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.